SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+8.08%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$275M
AUM Growth
+$275M
(+15%)
Cap. Flow
+$12.1M
Cap. Flow
% of AUM
4.41%
Top 10 Holdings %
Top 10 Hldgs %
40.4%
Holding
55
New
15
Increased
13
Reduced
16
Closed
8
Top Buys
| 1 |
SPDR S&P Biotech ETF
XBI
|
$15.6M |
| 2 |
Charles River Laboratories
CRL
|
$6.77M |
| 3 |
Edwards Lifesciences
EW
|
$6.69M |
| 4 |
Baxter International
BAX
|
$5.56M |
| 5 |
Avantor
AVTR
|
$5.47M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$7.5M |
| 2 |
Tenet Healthcare
THC
|
$7.36M |
| 3 |
Medtronic
MDT
|
$6.59M |
| 4 |
Zimmer Biomet
ZBH
|
$6.09M |
| 5 |
Universal Health Services
UHS
|
$5.02M |
Sector Composition
| 1 | Healthcare | 89.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR S&P Biotech ETF
XBI
$5.07B
| $28.5M | 6.67% |
300,000
+164,412
| +121% | +$15.6M |
|
2
Eli Lilly
LLY
$657B
| $12.4M | 2.92% |
16,000
+1,000
| +7% | +$778K |
|
3
Novo Nordisk
NVO
$251B
| $11.9M | 2.78% |
92,500
+2,500
| +3% | +$321K |
|
4
Boston Scientific
BSX
$156B
| $9.25M | 2.17% |
135,000
-25,000
| -16% | -$1.71M |
|
5
Thermo Fisher Scientific
TMO
$186B
| $9.01M | 2.11% |
15,500
+3,500
| +29% | +$2.03M |
|
6
Stryker
SYK
$150B
| $8.95M | 2.1% |
25,000
-3,000
| -11% | -$1.07M |
|
7
Intuitive Surgical
ISRG
$170B
| $7.98M | 1.87% |
20,000
-2,500
| -11% | -$998K |
|
|
8
Tenet Healthcare
THC
$16.3B
| $7.88M | 1.85% |
75,000
-70,000
| -48% | -$7.36M |
|
9
McKesson
MCK
$85.4B
| $7.78M | 1.82% |
14,500
-500
| -3% | -$268K |
|
10
Danaher
DHR
$147B
| $7.49M | 1.76% |
30,000
+5,000
| +20% | +$1.25M |
|
|
11
Universal Health Services
UHS
$11.6B
| $7.3M | 1.71% |
40,000
-27,500
| -41% | -$5.02M |
|
12
ResMed
RMD
$40.2B
| $7M | 1.64% |
35,361
+15,361
| +77% | +$3.04M |
|
13
Humana
HUM
$36.5B
| $6.93M | 1.63% |
20,000
+5,000
| +33% | +$1.73M |
|
|
14
Charles River Laboratories
CRL
$8.04B
| $6.77M | 1.59% |
+25,000
| New | +$6.77M |
|
|
15
Edwards Lifesciences
EW
$47.8B
| $6.69M | 1.57% |
+70,000
| New | +$6.69M |
|
16
Select Medical
SEM
$1.61B
| $6.03M | 1.41% |
200,000
-50,000
| -20% | -$1.51M |
|
17
Inspire Medical Systems
INSP
$2.77B
| $5.91M | 1.38% |
27,500
| – | – |
|
|
18
HCA Healthcare
HCA
$94.5B
| $5.84M | 1.37% |
17,500
-22,500
| -56% | -$7.5M |
|
19
Abbott
ABT
$231B
| $5.68M | 1.33% |
50,000
-2,500
| -5% | -$284K |
|
20
Surgery Partners
SGRY
$2.91B
| $5.67M | 1.33% |
190,000
-10,000
| -5% | -$298K |
|
|
21
Baxter International
BAX
$12.7B
| $5.56M | 1.3% |
+130,000
| New | +$5.56M |
|
22
Acadia Healthcare
ACHC
$2.12B
| $5.55M | 1.3% |
70,000
-20,000
| -22% | -$1.58M |
|
|
23
Avantor
AVTR
$9.18B
| $5.47M | 1.28% |
+213,947
| New | +$5.47M |
|
24
Smith & Nephew
SNN
$16.3B
| $5.2M | 1.22% |
205,000
+15,000
| +8% | +$380K |
|
25
Insulet
PODD
$23.9B
| $5.14M | 1.21% |
30,000
+3,500
| +13% | +$600K |
|